About
Advanced Ophthalmic Diagnostic Imaging Technology
RetSight is focused on developing innovative, low-cost ophthalmic diagnostic imaging systems. The companys technology provides large retinal coverage in a quick procedure designed to replace existing ophthalmic diagnostic devices. RetSights products aim to cover both the preterm infant and adult markets. The company plans to sell or lease its systems to hospitals, eye clinics, and ophthalmologists.
Identity
| Name | RetSight |
|---|---|
| Slug | retsight |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgIf5lIUKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | Rothschild Street 44, Caesarea, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyBabiesTeenagers & Young Adults
Business models
B2B
Tags
diagnosticssensorsmedical-technologieshospitalsclinicseye-diseasesdoctorsophthalmologyimaging
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}